Search

Your search keyword '"Tatyana Novoyatleva"' showing total 46 results

Search Constraints

Start Over You searched for: Author "Tatyana Novoyatleva" Remove constraint Author: "Tatyana Novoyatleva" Publication Year Range Last 50 years Remove constraint Publication Year Range: Last 50 years
46 results on '"Tatyana Novoyatleva"'

Search Results

1. C-type natriuretic peptide/cGMP/FoxO3 signaling attenuates hyperproliferation of pericytes from patients with pulmonary arterial hypertension

2. Deficiency of Axl aggravates pulmonary arterial hypertension via BMPR2

Catalog

Books, media, physical & digital resources

3. Author Correction: Deficiency of Axl aggravates pulmonary arterial hypertension via BMPR2

4. Correction to: Eplerenone attenuates pathological pulmonary vascular rather than right ventricular remodeling in pulmonary arterial hypertension

5. Impact of PCSK9 on CTRP9-Induced Metabolic Effects in Adult Rat Cardiomyocytes

6. Effect of p53 activation on experimental right ventricular hypertrophy.

7. Eplerenone attenuates pathological pulmonary vascular rather than right ventricular remodeling in pulmonary arterial hypertension

8. IRAG1 Deficient Mice Develop PKG1β Dependent Pulmonary Hypertension

9. Yarsagumba is a Promising Therapeutic Option for Treatment of Pulmonary Hypertension due to the Potent Anti-Proliferative and Vasorelaxant Properties

10. Cardiac deletion of Smyd2 is dispensable for mouse heart development.

12. Mining the Plasma Proteome for Insights into the Molecular Pathology of Pulmonary Arterial Hypertension

13. Role of the Purinergic P2Y2 Receptor in Pulmonary Hypertension

14. Adenylate Kinase 4—A Key Regulator of Proliferation and Metabolic Shift in Human Pulmonary Arterial Smooth Muscle Cells via Akt and HIF-1α Signaling Pathways

16. Therapeutic Potential of Regorafenib—A Multikinase Inhibitor in Pulmonary Hypertension

17. Therapeutic Potential of Regorafenib-A Multikinase Inhibitor in Pulmonary Hypertension

18. IRAG1 Deficient Mice Develop PKG1β Dependent Pulmonary Hypertension

19. Targeting peptidyl-prolyl isomerase 1 in experimental pulmonary arterial hypertension

20. ASK1 Inhibition Halts Disease Progression in Preclinical Models of Pulmonary Arterial Hypertension

21. p38 MAPK Inhibition Improves Heart Function in Pressure-Loaded Right Ventricular Hypertrophy

25. Yarsagumba is a Promising Therapeutic Option for Treatment of Pulmonary Hypertension due to the Potent Anti-Proliferative and Vasorelaxant Properties

26. Nitric Oxide Synthase 2 Induction Promotes Right Ventricular Fibrosis

27. Lysine methyltransferase Smyd2 suppresses p53-dependent cardiomyocyte apoptosis

28. FGF1‐mediated cardiomyocyte cell cycle reentry depends on the interaction of FGFR‐1 and Fn14

29. Response to: Comment on 'Effect of Riociguat and Sildenafil on Right Heart Remodeling and Function in Pressure Overload Induced Model of Pulmonary Arterial Banding'

30. Comment on 'Effect of Riociguat and Sildenafil on Right Heart Remodeling and Function in Pressure Overload Induced Model of Pulmonary Arterial Banding'

31. Organ-specific function of adhesion G protein-coupled receptor GPR126 is domain-dependent

32. Anti-fibrotic effects of pirfenidone on pulmonary arterial vascular smooth muscle cells

33. Nephronectin regulates atrioventricular canal differentiation via Bmp4-Has2 signaling in zebrafish

34. E2F4 is required for cardiomyocyte proliferation

35. TWEAK is a positive regulator of cardiomyocyte proliferation

36. Protein phosphatase 1 binds to the RNA recognition motif of several splicing factors and regulates alternative pre-mRNA processing

37. 5-HT2B Receptor Antagonists Inhibit Fibrosis and Protect from RV Heart Failure

38. Abstract 15100: Inhibition of P38 Mapk Improves Heart Function in Sustained Pressure-overload Induced Right Ventricular Hypertrophy and Failure

39. TWEAK-Fn14 Cytokine-Receptor Axis: A New Player of Myocardial Remodeling and Cardiac Failure

40. TWEAK/Fn14 axis is a positive regulator of cardiac hypertrophy

43. Pre-mRNA missplicing as a cause of human disease

44. Pre-mRNA Missplicing as a Cause of Human Disease

45. p59(fyn)-mediated phosphorylation regulates the activity of the tissue-specific splicing factor rSLM-1

46. Correction for Patra et al., Organ-specific function of adhesion G protein-coupled receptor GPR126 is domain-dependent